2008
Estimation of HIV Incidence in the United States
Hall HI, Song R, Rhodes P, Prejean J, An Q, Lee LM, Karon J, Brookmeyer R, Kaplan EH, McKenna MT, Janssen RS, Group F. Estimation of HIV Incidence in the United States. JAMA 2008, 300: 520-529. PMID: 18677024, PMCID: PMC2919237, DOI: 10.1001/jama.300.5.520.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusHIV incidenceHIV infectionBED HIV-1 capture enzyme immunoassayIncidence of HIVNew infectionsPatients 13 yearsNew HIV infectionsPercent of infectionsClinic-based settingBlack individualsCapture enzyme immunoassayHIV diagnosisHIV casesImmunodeficiency virusRecent infectionIncidence rateMAIN OUTCOMEDiagnostic seraAIDS incidenceDisease controlInfectionEnzyme immunoassayIncidenceDiagnostic specimens
2001
Public Health Consequences of Screening Patients for Adherence to Highly Active Antiretroviral Therapy
Tchetgen E, Kaplan E, Friedland G. Public Health Consequences of Screening Patients for Adherence to Highly Active Antiretroviral Therapy. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2001, 26: 118-129. PMID: 11242178, DOI: 10.1097/00042560-200102010-00003.Peer-Reviewed Original ResearchConceptsActive antiretroviral therapyAntiretroviral therapyDrug resistanceDrug-resistant virusesNew HIV infectionsHIV antiretroviral therapyImportance of adherencePublic health consequencesHIV patientsHIV infectionTreatment regimensScreening patientsAIDS casesPatient benefitPhysician's abilityPatientsAIDS incidenceTherapyHealth consequencesAdherenceRecent studiesPopulation levelHAARTRegimensHIVPublic Health Consequences of Screening Patients for Adherence to Highly Active Antiretroviral Therapy
Tchetgen E, Kaplan E, Friedland G. Public Health Consequences of Screening Patients for Adherence to Highly Active Antiretroviral Therapy. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2001, 26: 118-129. DOI: 10.1097/00126334-200102010-00003.Peer-Reviewed Original ResearchConceptsActive antiretroviral therapyAntiretroviral therapyDrug resistanceDrug-resistant virusesNew HIV infectionsHIV antiretroviral therapyImportance of adherencePublic health consequencesHIV patientsHIV infectionTreatment regimensScreening patientsAIDS casesPatient benefitPhysician's abilityPatientsAIDS incidenceTherapyHealth consequencesAdherenceRecent studiesPopulation levelHAARTRegimensHIV
2000
Repeat screening for HIV: when to test and why.
Kaplan E, Satten G. Repeat screening for HIV: when to test and why. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2000, 23: 339-45. PMID: 10836757, DOI: 10.1097/00126334-200004010-00010.Peer-Reviewed Original ResearchRepeat Screening for HIV: When to Test and Why
Kaplan E, Satten G. Repeat Screening for HIV: When to Test and Why. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2000, 23: 339-345. DOI: 10.1097/00042560-200004010-00010.Peer-Reviewed Original Research
1999
New approaches to HIV surveillance: means and ends. Summary report of conference held at Yale University, 21-22 May 1998, by the Law, Policy and Ethics Core, Center for Interdisciplinary Research on AIDS, Yale University.
Johri M, Kaplan E, Levi J, Novick A. New approaches to HIV surveillance: means and ends. Summary report of conference held at Yale University, 21-22 May 1998, by the Law, Policy and Ethics Core, Center for Interdisciplinary Research on AIDS, Yale University. AIDS & Public Policy Journal 1999, 14: 136-46. PMID: 11148944.Peer-Reviewed Original ResearchCenters for Disease Control and Prevention, U.S.ConfidentialityContact TracingData CollectionData Interpretation, StatisticalDisease NotificationForecastingHIV InfectionsHumansIncidenceMandatory TestingMass ScreeningMedical Record LinkageOrganizational ObjectivesPopulation SurveillancePrevalenceReproducibility of ResultsUnited States
1998
A mathematical model of HIV transmission in NSW prisons
Dolan K, Wodak A, Hall W, Kaplan E. A mathematical model of HIV transmission in NSW prisons. Drug And Alcohol Dependence 1998, 50: 197-202. PMID: 9649972, DOI: 10.1016/s0376-8716(98)00009-x.Peer-Reviewed Original ResearchIsrael's ban on use of Ethiopians' blood: how many infectious donations were prevented?
Kaplan E. Israel's ban on use of Ethiopians' blood: how many infectious donations were prevented? The Lancet 1998, 351: 1127-1128. PMID: 9660600, DOI: 10.1016/s0140-6736(97)10356-7.Peer-Reviewed Original ResearchHIV Incidence in Ethiopian Immigrants to Israel
Kaplan E, Kedem E, Pollack S. HIV Incidence in Ethiopian Immigrants to Israel. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1998, 17: 465-469. PMID: 9562050, DOI: 10.1097/00042560-199804150-00012.Peer-Reviewed Original Research
1995
HIV Incidence Among New Haven Needle Exchange Participants
Kaplan E, Heimer R. HIV Incidence Among New Haven Needle Exchange Participants. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1995, 10: 175-176. PMID: 7552482, DOI: 10.1097/00042560-199510020-00010.Peer-Reviewed Original ResearchEconomic analysis of needle exchange
Kaplan E. Economic analysis of needle exchange. AIDS 1995, 9: 1113-1120. PMID: 8519446, DOI: 10.1097/00002030-199510000-00001.Peer-Reviewed Original Research
1994
A method for evaluating needle exchange programmes
Kaplan E. A method for evaluating needle exchange programmes. Statistics In Medicine 1994, 13: 2179-2187. PMID: 7846418, DOI: 10.1002/sim.4780131923.Peer-Reviewed Original ResearchA circulation theory of needle exchange
Kaplan E, Heimer R. A circulation theory of needle exchange. AIDS 1994, 8: 567-574. PMID: 8060540, DOI: 10.1097/00002030-199405000-00001.Peer-Reviewed Original ResearchHIV incidence among needle exchange participants: estimates from syringe tracking and testing data.
Kaplan E, Heimer R. HIV incidence among needle exchange participants: estimates from syringe tracking and testing data. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1994, 7: 182-9. PMID: 8301530.Peer-Reviewed Original Research
1993
Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut
Heimer R, Kaplan E, Khoshnood K, Jariwala B, Cadman E. Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut. The American Journal Of Medicine 1993, 95: 214-220. PMID: 8356986, DOI: 10.1016/0002-9343(93)90263-o.Peer-Reviewed Original ResearchConceptsHIV-1 proviral DNANeedle exchange programsProviral DNANew Haven's needle exchange programNeedle exchangeHIV-1 prevalenceIntravenous drug usersNeedle exchange clientsDrug treatment programsPercentage of syringesDrug use habitsSyringe trackingDNA prevalenceNew HavenPolymerase chain reactionDrug treatmentDrug usersTreatment programPrevalenceChain reactionExchange programsSyringesMonthsProgram participantsFunded evaluation
1992
Prevalence of HIV-Infected Syringes during a Syringe-Exchange Program
Heimer R, Kaplan E, Cadman E. Prevalence of HIV-Infected Syringes during a Syringe-Exchange Program. New England Journal Of Medicine 1992, 327: 1883-1884. PMID: 1448131, DOI: 10.1056/nejm199212243272613.Peer-Reviewed Original ResearchNeedle exchange or needless exchange? The state of the debate.
Kaplan E. Needle exchange or needless exchange? The state of the debate. Infectious Agents And Disease 1992, 1: 92-8. PMID: 1365534.Peer-Reviewed Original ResearchConceptsNeedle exchange programsNeedle exchangeHuman immunodeficiency virus (HIV) infectionImmunodeficiency virus infectionDrug injection equipmentHIV incidenceVirus infectionDrug usersMatter of debateProgram clientsOngoing studiesInjection equipmentFurther investigationExchange programsNew HavenInfectionIncidenceCTAsymptotic worst-case mixing in simple demographic models of HIV/AIDS
Kaplan E. Asymptotic worst-case mixing in simple demographic models of HIV/AIDS. Mathematical Biosciences 1992, 108: 141-156. PMID: 1550996, DOI: 10.1016/0025-5564(92)90009-l.Peer-Reviewed Original ResearchHIV prevalence among intravenous drug users: model-based estimates from New Haven's legal needle exchange.
Kaplan E, Heimer R. HIV prevalence among intravenous drug users: model-based estimates from New Haven's legal needle exchange. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1992, 5: 163-9. PMID: 1732509.Peer-Reviewed Original ResearchA model-based estimate of HIV infectivity via needle sharing.
Kaplan E, Heimer R. A model-based estimate of HIV infectivity via needle sharing. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1992, 5: 1116-8. PMID: 1403641.Peer-Reviewed Original Research